263 related articles for article (PubMed ID: 10821852)
21. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo.
Mao Y; Ling PR; Fitzgibbons TP; McCowen KC; Frick GP; Bistrian BR; Smith RJ
Endocrinology; 1999 Dec; 140(12):5505-15. PubMed ID: 10579313
[TBL] [Abstract][Full Text] [Related]
22. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro.
Ling C; Billig H
Endocrinology; 2001 Nov; 142(11):4880-90. PubMed ID: 11606456
[TBL] [Abstract][Full Text] [Related]
23. In vivo regulation of growth hormone-stimulated gene transcription by STAT5b.
Woelfle J; Rotwein P
Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E393-401. PubMed ID: 14761873
[TBL] [Abstract][Full Text] [Related]
24. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.
Denson LA; Held MA; Menon RK; Frank SJ; Parlow AF; Arnold DL
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G646-54. PubMed ID: 12519742
[TBL] [Abstract][Full Text] [Related]
26. Asb6, an adipocyte-specific ankyrin and SOCS box protein, interacts with APS to enable recruitment of elongins B and C to the insulin receptor signaling complex.
Wilcox A; Katsanakis KD; Bheda F; Pillay TS
J Biol Chem; 2004 Sep; 279(37):38881-8. PubMed ID: 15231829
[TBL] [Abstract][Full Text] [Related]
27. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.
Senn JJ; Klover PJ; Nowak IA; Zimmers TA; Koniaris LG; Furlanetto RW; Mooney RA
J Biol Chem; 2003 Apr; 278(16):13740-6. PubMed ID: 12560330
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
[TBL] [Abstract][Full Text] [Related]
29. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
30. Stat5 is a physiological substrate of the insulin receptor.
Chen J; Sadowski HB; Kohanski RA; Wang LH
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2295-300. PubMed ID: 9122188
[TBL] [Abstract][Full Text] [Related]
31. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b.
Zhou YC; Waxman DJ
J Biol Chem; 1999 Jan; 274(5):2672-81. PubMed ID: 9915797
[TBL] [Abstract][Full Text] [Related]
32. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
Park SH; Yamashita H; Rui H; Waxman DJ
Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
[TBL] [Abstract][Full Text] [Related]
33. Effects of cardiotrophin on adipocytes.
Zvonic S; Hogan JC; Arbour-Reily P; Mynatt RL; Stephens JM
J Biol Chem; 2004 Nov; 279(46):47572-9. PubMed ID: 15339920
[TBL] [Abstract][Full Text] [Related]
34. Cis desensitizes GH induced Stat5 signaling in rat liver cells.
Karlsson H; Gustafsson JA; Mode A
Mol Cell Endocrinol; 1999 Aug; 154(1-2):37-43. PubMed ID: 10509798
[TBL] [Abstract][Full Text] [Related]
35. SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor.
Ali S; Nouhi Z; Chughtai N; Ali S
J Biol Chem; 2003 Dec; 278(52):52021-31. PubMed ID: 14522994
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
37. STAT5b down-regulates peroxisome proliferator-activated receptor alpha transcription by inhibition of ligand-independent activation function region-1 trans-activation domain.
Zhou YC; Waxman DJ
J Biol Chem; 1999 Oct; 274(42):29874-82. PubMed ID: 10514468
[TBL] [Abstract][Full Text] [Related]
38. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b).
Greenhalgh CJ; Bertolino P; Asa SL; Metcalf D; Corbin JE; Adams TE; Davey HW; Nicola NA; Hilton DJ; Alexander WS
Mol Endocrinol; 2002 Jun; 16(6):1394-406. PubMed ID: 12040024
[TBL] [Abstract][Full Text] [Related]
39. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K
Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496
[TBL] [Abstract][Full Text] [Related]
40. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes.
Dogusan Z; Hooghe R; Verdood P; Hooghe-Peters EL
J Neuroimmunol; 2001 Nov; 120(1-2):58-66. PubMed ID: 11694320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
